Ching‐Chih Lin

513 total citations
22 papers, 298 citations indexed

About

Ching‐Chih Lin is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ching‐Chih Lin has authored 22 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Ching‐Chih Lin's work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Ching‐Chih Lin is often cited by papers focused on Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Ching‐Chih Lin collaborates with scholars based in Taiwan, United States and United Kingdom. Ching‐Chih Lin's co-authors include Yi‐Ren Hong, Shen‐Long Howng, Ching‐Mei Hsu, Ming‐Chang Yang, Joon‐Khim Loh, An‐Kuo Chou, Jiin‐Tsuey Cheng, Chih‐Chang Wei, Chia‐Yen Dai and Ming‐Lung Yu and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Ching‐Chih Lin

19 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching‐Chih Lin Taiwan	9	183	59	48	43	34	22	298
John M. Viola United States	6	318 1.7×	92 1.6×	148 3.1×	5 0.1×	125 3.7×	8	530
Vahid Hosseini Iran	12	172 0.9×	11 0.2×	51 1.1×	24 0.6×	21 0.6×	23	344
Rongxin Chen China	10	145 0.8×	80 1.4×	71 1.5×	38 0.9×	16 0.5×	15	321
Nurjati Chairani Siregar Indonesia	12	123 0.7×	42 0.7×	72 1.5×	27 0.6×	9 0.3×	45	307
Guo Lv China	8	155 0.8×	57 1.0×	67 1.4×	49 1.1×	10 0.3×	12	274
Shi‐Jun Xu China	10	147 0.8×	46 0.8×	85 1.8×	40 0.9×	22 0.6×	27	307
Di Ding China	10	180 1.0×	47 0.8×	127 2.6×	30 0.7×	12 0.4×	22	305
Aitor Andueza United States	5	156 0.9×	34 0.6×	32 0.7×	16 0.4×	24 0.7×	10	265
Christine Yee Australia	9	114 0.6×	82 1.4×	16 0.3×	36 0.8×	31 0.9×	19	304
Hwee Hui Lau Singapore	9	212 1.2×	44 0.7×	33 0.7×	32 0.7×	8 0.2×	14	428

Countries citing papers authored by Ching‐Chih Lin

Since Specialization

Citations

This map shows the geographic impact of Ching‐Chih Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chih Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chih Lin more than expected).

Fields of papers citing papers by Ching‐Chih Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Chih Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chih Lin. The network helps show where Ching‐Chih Lin may publish in the future.

Co-authorship network of co-authors of Ching‐Chih Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Chih Lin. A scholar is included among the top collaborators of Ching‐Chih Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Chih Lin. Ching‐Chih Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jang, Tyng‐Yuan, Chih‐Wen Wang, Po‐Cheng Liang, et al.. (2025). Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B. Journal of Gastroenterology and Hepatology. 40(9). 2290–2299.

Wei, Yu‐Ju, Chih‐Wen Wang, Po‐Cheng Liang, et al.. (2025). Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes. World Journal of Gastroenterology. 31(10). 103716–103716. 1 indexed citations

Tsai, Mi‐Ching, et al.. (2024). Machine learning applied to property prediction of metal additive manufacturing products with textural features extraction. The International Journal of Advanced Manufacturing Technology. 132(1-2). 83–98. 7 indexed citations

Lin, Ching‐Chih, et al.. (2024). Enhancing measurement efficiency for 3D printed magnet through radial basis function interpolation. Journal of Magnetism and Magnetic Materials. 602. 172192–172192.

Lin, Ching‐Chih & Mi‐Ching Tsai. (2023). 3D magnetic flux density measurement with reduced sampling and high accuracy using visual localization and adaptive mesh generation. The International Journal of Advanced Manufacturing Technology. 130(5-6). 2985–2998. 1 indexed citations

Lin, Ching‐Chih, et al.. (2022). Deep Learning Applied to Defect Detection in Powder Spreading Process of Magnetic Material Additive Manufacturing. Materials. 15(16). 5662–5662. 15 indexed citations

Su, Chun‐Han, Yu-Chieh Cheng, Kuei-Hung Lai, et al.. (2022). Exploring the relationship between metabolite composition and the cold/hot properties ascribed in traditional Chinese medicine by mass spectral molecular networking–a pilot study. Journal of Food and Drug Analysis. 30(3). 402–416. 3 indexed citations

Wang, Shu‐Chi, Chia‐Yang Li, Wen‐Tsan Chang, et al.. (2020). Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence. Liver International. 41(5). 956–968. 22 indexed citations

Lin, Ching‐Chih, Ta-Wei Liu, Ming‐Lun Yeh, et al.. (2020). Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognos- tic factor in hepatitis C virus-related hepatocellular carcinoma. Clinical and Molecular Hepatology. 27(2). 313–328. 12 indexed citations

10.

Liu, Ta-Wei, Pei‐Chien Tsai, Ching‐I Huang, et al.. (2017). Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort. Journal of the Formosan Medical Association. 117(1). 54–62. 2 indexed citations

11.

Tsai, Pei‐Chien, Ta-Wei Liu, Yi‐Shan Tsai, et al.. (2017). Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database. Medicine. 96(22). e6984–e6984. 4 indexed citations

12.

Huang, Chung‐Feng, Ching‐I Huang, Ming‐Lun Yeh, et al.. (2017). Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. Oncotarget. 8(20). 32618–32625. 5 indexed citations

13.

Foster, Graham R., Edward Gane, Armen Asatryan, et al.. (2016). Endurance-3: A Phase 3, Randomized, Open-Label, Active-Controlled Study to Compare Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Co-Administered with Daclatasvir in Adults with HCV Genotype 3 Infection. Journal of Hepatology. 64(2). S292–S292. 2 indexed citations

14.

Huang, Chung‐Feng, Ming‐Lun Yeh, Shu‐Chi Wang, et al.. (2016). Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment. EBioMedicine. 15. 81–89. 32 indexed citations

15.

Loh, Joon‐Khim, Ching‐Chih Lin, Ming‐Chang Yang, et al.. (2015). GSKIP- and GSK3-mediated anchoring strengthens cAMP/PKA/Drp1 axis signaling in the regulation of mitochondrial elongation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(8). 1796–1807. 27 indexed citations

16.

Loh, Joon‐Khim, Ann‐Shung Lieu, Ching‐Chih Lin, et al.. (2012). Differential expression of centrosome‐associated proteins in human brain tumors: A possible role of hNinein isoform 6 in cell differentiation. BioFactors. 38(6). 470–477. 5 indexed citations

17.

Lin, Ching‐Chih, Ming‐Chang Yang, Chih‐Chang Wei, et al.. (2012). GSK3beta-Mediated Drp1 Phosphorylation Induced Elongated Mitochondrial Morphology against Oxidative Stress. PLoS ONE. 7(11). e49112–e49112. 106 indexed citations

18.

Hong, Yi‐Ren, et al.. (2012). GSK3beta regulates Bcl2L12 and Bcl2L12A anti‐apoptosis signaling in glioblastoma and is inhibited by LiCl. The FASEB Journal. 26(S1). 5 indexed citations

19.

Lin, Ching‐Chih, Shen‐Long Howng, Chia‐Yi Hsu, et al.. (2009). GSKIP, an inhibitor of GSK3β, mediates the N‐cadherin/β‐catenin pool in the differentiation of SH‐SY5Y cells. Journal of Cellular Biochemistry. 108(6). 1325–1336. 23 indexed citations

20.

Lin, Ching‐Chih, Chi‐Fong Lin, Ying‐Ting Lin, et al.. (2008). 2-(6-Aryl-3(Z)-hexen-1,5-diynyl)anilines as a New Class of Potent Antitubulin Agents. Journal of Medicinal Chemistry. 51(9). 2682–2688. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact